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<BEGIN ABSTRACT>Objective: Behavioral interventions are recommended as attention-
deficit/hyperactivity disorder (ADHD) treatments. However, a recent meta-analysis found no 
effects on core ADHD symptoms when raters were probably blind to treatment allocation. The 
present analysis is extended to a broader range of child and parent outcomes. Method: A 
systematic search in PubMed, Ovid, Web of Knowledge, ERIC, and CINAHAL databases (up 
to February 5, 2013) identified published randomized controlled trials measuring a range of 
patient and parent outcomes for children and adolescents diagnosed with ADHD (or who met 
validated cutoffs on rating scales). Results: Thirty-two of 2,057 nonduplicate screened records 
were analyzed. For assessments made by individuals closest to the treatment setting (usually 
unblinded), there were significant improvements in parenting quality (standardized mean 
difference [SMD] for positive parenting 0.68; SMD for negative parenting 0.57), parenting self-
concept (SMD 0.37), and child ADHD (SMD 0.35), conduct problems (SMD 0.26), social skills 
(SMD 0.47), and academic performance (SMD 0.28). With probably blinded assessments, 
significant effects persisted for parenting (SMD for positive parenting 0.63; SMD for negative 
parenting 0.43) and conduct problems (SMD 0.31). Conclusion: In contrast to the lack of 
blinded evidence of ADHD symptom decrease, behavioral interventions have positive effects on 
a range of other outcomes when used with patients with ADHD. There is blinded evidence that 
they improve parenting and decrease childhood conduct problems. These effects also may feed 
through into a more positive parenting self-concept but not improved parent mental well-being. 
J. Am. Acad. Child Adolesc. Psychiatry, 2014;16(x):xx–xx. Key Words: ADHD, parenting, 
intervention, conduct<END ABSTRACT> 
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Attention-deficit/hyperactivity disorder (ADHD) is characterized by age-inappropriate, persistent, and 
pervasive inattention and/or overactivity/impulsiveness that impairs daily functioning1 and is associated 
with substantial long-term burden on patients, families, and health and educational services.2,3 Multimodal 
treatment approaches are recommended.4 Medication is typically used as the first-line intervention, 
especially for severe cases.5 Despite robust evidence of medium-term symptom control,6 medication has 
some limitations. A proportion of patients shows partial or no response.6 Long-term effectiveness remains 
to be established.7,8 Important aspects of functioning may not improve (e.g., academic achievement9). 
Adverse effects on sleep, appetite, and growth, although rarely serious and generally manageable, are 
common and may not be well tolerated.10 Treatment compliance can be low, especially during 
adolescence.11 Parents and clinicians can have reservations about medication use12 and may prefer 
nonpharmacologic approaches.13 
Interventions using behavioral techniques also are recommended and commonly used as ADHD 
treatments.14 Systematic reviews of treatment trials have provided evidence to support their efficacy.15-17 
However, these reviews can be difficult to interpret, because they sometimes include nonrandomized 
controlled trials (RCTs), mix individuals with and without ADHD, and have not always drawn clear 
boundaries between ADHD-specific and other outcomes. Furthermore, outcome assessment is often made 
unblinded by individuals taking an active part in the intervention (e.g., parents receiving parent training), 
which is likely to inflate efficacy estimates.18 Sonuga-Barke et al.19 published a meta-analysis of RCTs of 
behavioral interventions. Stringent inclusion and exclusion criteria addressed some limitations of previous 
meta-analyses. There was a moderate, statistically significant, positive effect on ADHD core symptoms 
for assessments made by individuals most proximal to the therapeutic setting—typically unblinded parent 
ratings. However, these effects were not corroborated by probably blinded measurements made by 
observers or raters unaware of treatment allocation when the effect size decreased to near 0 and became 
nonsignificant. A similar, although less marked, decrease was found for neural feedback and cognitive 
training. There are some possible explanations for these findings. First, that unblinded raters are biased 
and overestimate treatment effects.20 Second, that interventions increase parental tolerance for ADHD or 
their ability to cope with its negative impact rather than decreasing symptom levels.19 Third, that probably 
blinded measurements were less valid than most proximal measurements.21 Fourth, that intervention 
effects did not generalize from the therapeutic setting (e.g., the home) to other settings (e.g., school).22 
The authors concluded that more evidence from studies with blinded assessments is required before 
behavioral interventions can be supported as treatments for core ADHD symptoms. 
The limited effects of behavioral approaches on blinded core ADHD measurements may be 
explicable if one considers the treatment models on which many are based. For instance, although most 
treatments in the trials included in the meta-analysis of Sonuga-Barke et al.19 were implemented to target 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
ADHD symptoms, they were initially developed and have been used extensively for children with 
oppositional and conduct problems.23-25 For many of these, the rationale is that children’s challenging 
behavior develops because of coercive interactional cycles that, over time, co-reinforce noncompliant and 
oppositional behaviors in the child and negative and inappropriate responses from significant adults 
(usually the parent but also potentially teachers and other caregivers).26 During intervention, the adult is 
taught to apply behavior modification techniques to reinforce appropriate and discourage inappropriate 
child behaviors, enhance effective and enjoyable adult–child interactions,27 and so transform negative into 
positive interactional cycles. Such interventions, it could be argued, are unlikely to be effective as 
treatments for core ADHD symptoms because ADHD does not emerge along a similar environmentally 
mediated route as conduct problems and therefore is less likely to respond to the modification of 
environmental contingencies.28 
However, the value of behavioral interventions does not rest exclusively on their potential effects on 
ADHD symptoms. Patients with ADHD often have conduct problems29 and other comorbidities30 in 
addition to poor social and organizational skills and low academic achievement. Their parents can have 
poor parenting self-concept and mental health problems.31 These associated features of the disorder are 
important treatment targets in and of themselves, because each is associated with substantial burden to the 
child, the child’s family, and society through the criminal justice, social, and health systems.22,32 
Behavioral interventions may have an important role in treating these problems whether or not they 
decrease core ADHD symptoms. Indeed, behavioral treatments used with patients with ADHD have 
targeted ADHD-related but nonspecific aspects of impairment rather than ADHD symptoms themselves 
(e.g., social skills,33 organizational skills,34 and academic achievement35). 
In this article, the authors build on the previous meta-analysis19 to address the broader impact of 
behavioral interventions for children with ADHD. They address 3 related questions. First, given that 
most, although not all, interventions are implemented by changes in the behavior of responsible adults 
(typically parents or teachers), do behavioral interventions improve adult responses to children with 
ADHD? Second, do they improve the sense of efficacy and competence and decrease the mental health 
problems of adults working with children with ADHD? Third, do they decrease levels of child 
oppositional behavior and other comorbidities and other aspects of impairment such as social skills and 
academic performance? To address these questions, most proximal and probably blinded assessments 
were contrasted. 
<H1>Method 
Please see the registered protocol CRD42011001393 (link deleted to blind the identity of the authors) for 
more details. 
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<H2>Inclusion Criteria 
Only published peer-reviewed RCTs were included, although the authors acknowledge that many well-
designed studies using single-subject research designs examining the effects of behavioral interventions 
have been published. Following the recommendation of the Cochrane group, the search was limited to 
published trials to ensure a level of methodologic adequacy and rigor among included trials and to avoid 
the inevitable problems with securing access to a full set of unpublished trials and the bias that this would 
introduce.36 Participants needed to be 3 to 18 years old and have an ADHD diagnosis (any subtype) or 
have met accepted cutoffs on validated ADHD rating scales. Trials involving only rare comorbid 
disorders (e.g., fragile X syndrome) were excluded. Acceptable control conditions were “treatment as 
usual,” “wait list,” or “active” controls. “Treatment as usual” could include medication, but trials were 
excluded if the behavioral intervention was an adjunct to medication or if pharmacologic and behavioral 
interventions were combined into 1 therapeutic arm as part of the study design. For the present extended 
review, trials could be included despite not having an ADHD-related outcome (as required in the original 
protocol). 
<H2>Search Strategy 
The search was updated to February 5, 2013. Drs. Cortese and Ferrin blindly conducted and cross-
checked the updated search using the same databases, search strategy, and search terms as used 
previously19 (see protocol). The searches were conducted for records included from the inception of the 
databases. Behavioral interventions were defined as those interventions directed at changing behaviors 
(increasing desired and decreasing undesired behaviors). They encompass classic contingency 
management, behavior therapy (mainly through mediators such as parents or teachers), and cognitive 
behavior therapy (such as verbal self-instruction, problem-solving strategies, or social skills training). The 
treatment search terms covered a wide variety of intervention types with the aim of including trials 
involving any form of behaviorally based therapies, implemented in any setting (home or school), and 
indirectly by an adult or directly to the child (see protocol). 
<H2>Outcome Measurements 
To increase analytical robustness, outcome domains were only considered if at least 5 RCTs were 
available. Outcome measurements meeting this criterion were pre- to post-treatment changes in positive 
and negative parenting, parent mental health (e.g., anxiety, depression) and parenting self-concept (e.g., 
sense of competence and efficacy), child ADHD, conduct problems (i.e., negative and noncompliant 
behavior including symptoms of oppositional defiance and conduct disorders), social skills, and academic 
achievement. There were too few RCTs (n < 5) to examine changes in teacher behavior and well-being, 
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child impairment, internalizing problems, executive/organizational skills, or more general measurements 
of family functioning. 
<H2>Study Selection 
Article titles and abstracts were screened. Final inclusion was based on the full text. Trials were blindly 
double-coded for eligibility. Study quality was assessed by 2 independent raters according to the criteria 
of Jadad et al.37 (Table 1).24,25,33-35,40-66 These provide a rating for each trial in terms of standard definitions 
for randomization, blinding, and treatment of missing data defined by Jadadet al.37 Jadad scores for 
blinding were adapted for use with multiple outcomes so that studies with at least 1 blinded outcome 
yielded a score of 1 on this dimension. A score of at least 3 is regarded as indicating acceptable quality. 
Initial disagreements (n = 4) were resolved by the coders through discussion without recourse to an 
independent arbitrator. 
<H2>Data Extraction and Statistical Analysis 
Trial information was entered into RevMan 5.1 (http://ims.cochrane.org/revman).38 Data extraction was 
independently rated by 2 authors. The standardized mean difference (SMD), namely the mean pre- to 
post-treatment change minus the mean pre- to post-treatment control group change divided by the pooled 
pretest standard deviation with a bias adjustment, was calculated.39 SMDs for trials in each domain were 
combined using the inverse-variance method.36 Given the inherent heterogeneity of studies, random-
effects models were used. The I2 statistic was calculated, a posteriori, to estimate between-trial SMD 
heterogeneity. Most proximal and probably blinded analyses were performed for all domains except 
parent mental health, parenting self-concept, child social skills, and academic outcomes for which 
insufficient trials with probably blinded measurements were available. When multiple measurements were 
available for an outcome, the one most frequently reported across included trials was included. For the 
most proximal analysis, parent ratings, if available, were used, except for teacher-based interventions, 
when teacher ratings or direct observations were preferred. Probably blinded assessments were made by 
an individual likely to be blind to allocation. In trials in which more than 1 such measurement was 
available, the best blinded measurement was selected. This affected only trials with a home-based element 
where direct observations by an independent researcher and teacher ratings were the probably blinded 
measurement. In such cases, direct observation was selected over teacher ratings. Sensitivity analyses 
examined the impact of background ADHD medication use in trial samples for which at least 3 trials had 
fewer than 30% of participants receiving medications (i.e., were no-/low-medication trials) and the effects 
of outliers identified using funnel plots within RevMan 5.1.38 Meta-regression tested whether effect sizes 
were larger in lower-quality trials according to Jadad et al.37 For 1 study,34 2 active treatment arms were 
suitable for analysis. Parents and Teachers Helping Children Organize and Organizational Skills 
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Treatment yielded similar results; so only 1 arm, Parents and Teachers Helping Children Organize, which 
was considered the more standard behavioral intervention, was included in the final analysis. For another 
study,40 outcomes were taken from 3 publications.40-42 
<H1>Results 
Thirty-two studies met the entry criteria and had data amenable to analysis. Eight had a Jadad study 
quality rating of at least 3.33 Thirty-one studies had a parent-based component implemented at home. Four 
had an additional school-based, teacher-focused element. Fourteen included direct intervention with the 
child. Although most used standard behavioral principles and targeted children’s externalizing behaviors 
(ADHD, oppositional defiance disorder, conduct disorder), some implemented specialized social (n = 3), 
organizational (n = 3), or academic (n = 1) skills. Figure 1 presents the trial selection flowchart. Tables 1 
and 2 present information about included trials and the measurements used in each analysis, respectively. 
<H2>Do Behavioral Interventions Improve Adult Responses to Children with ADHD? 
No trials measured responses to children with ADHD by adults other than parents (i.e., no teachers). Nine 
trials measured positive parenting. Three most proximal measurements were parent rated; 5 were 
observational. Eight trials had probably blinded measurements, all observational. For positive parenting, 
most proximal effects were significant (SMD 0.68; 95% confidence interval [CI] 0.27-1.09; Figure 2 
shows forest plots). Effects were similar for probably blinded outcomes (SMD 0.63, 95% CI 0.47-0.78). 
Heterogeneity was significant in the 2 analyses (χ2 for most proximal = 63.55, I2 = 87%, p < .01; χ2 for 
probably blinded = 40.58, I2 = 83%, p < .01). Effects were unaffected by limiting the analyses to no-/low-
medication trials (n = 5, SMD for most proximal 1.23, 95% CI 0.26-2.20; n = 4, SMD for probably 
blinded 0.89, 95% CI 0.65-2.13), although heterogeneity remained high (χ2 for most proximal = 28.35, 
I2 = 89%, p < .01; χ2 probably blinded = 23.29, I2 = 87%, p < .01). Removing outliers decreased effect 
sizes (n = 2, SMD most proximal 0.32, 95% CI −0.06 to 0.58; n = 1, SMD probably blinded 0.44, 95% CI 
0.14-0.75). Heterogeneity was no longer significant (χ2 most proximal = 3.46, I2 = 0%, p = .48; χ2 for 
probably blinded = 0.83, I2 = 0%, p = .66). Fourteen trials measured negative parenting. The 9 most 
proximal measurements were parent ratings (4 observations and 1 speech sample). Eight studies met 
criteria for probably blinded assessments (7 observations and 1 speech sample). For negative parenting, 
effects were significant for the 2 analyses (SMD for most proximal 0.57, 95% CI 0.37-0.78; SMD for 
probably blinded 0.43, 95% CI 0.24-0.62). Heterogeneity also was significant (χ2 for most proximal = 
32.7, I2 = 60%, p < .01; χ2 for probably blinded = 19.8, I2 = 65%, p < .01). Most proximal effects were 
unchanged when no-/low-medication trials were analyzed (n = 7, SMD 0.57, 95% CI 0.22-0.92, χ2 = 7.81, 
I2 = 49%, p < .01), but effects became nonsignificant for probably blinded outcomes (n = 6, SMD 0.42, 
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95% CI −0.07 to 0.91, χ2 = 14.25, I2 = 72%, p < .01). When outliers were excluded, effects remained 
significant for the 2 outcomes (n = 2, SMD for most proximal 0.45, 95% CI 0.31-0.58; n = 1, SMD for 
probably blinded 0.36, 95% CI 0.12-0.60). Heterogeneity was decreased for one (χ2 for most proximal = 
15.45, I2 = 35%, p = .12) but not the other (χ2 for probably blinded = 15.03, I2 = 73%, p < .01). 
<H2>Do Behavioral Interventions Improve the Self-Concept and Mental Health of Adults 
Working with Children with ADHD? 
No trials measured the self-concept and mental health of adults other than parents. Seven trials included 
self-ratings of parental self-concept (6 parenting efficacy/sense of competence, 1 parenting self-esteem). 
There was a small but significant improvement in self-concept after treatment (SMD 0.37, 95% CI 0.03-
0.70). Heterogeneity was significant (χ2 = 19.03, I2 = 68%, p < .01). Effects increased slightly in no-/low-
medication trials (n = 5, SMD 0.68, 95% CI 0.22-0.92), whereas heterogeneity decreased substantially 
(χ2 = 0.99, I2 = 0%, p = .61). When outliers were removed (n = 1), effects and their heterogeneity were 
decreased to nonsignificant levels (SMD 0.30, 95% CI −0.07 to 0.65, χ2 = 5.24, I2 = 4%, p = .39). 
Measurements of self-rated parent mental health were included in 9 studies (7 depression/anxiety, 2 more 
general well-being). There were no significant effects of treatment (SMD 0.09, 95% CI −0.09 to 0.23; no-
/low-medication analysis, n = 6, SMD 0.09, 95% CI −0.19 to 0.37, p = .13; χ2 = 5.63, I2 = 47%, p < .01). 
No outliers were identified. 
<H2>Do Behavioral Interventions Decrease Child Psychopathology and Improve Functioning? 
Nineteen studies had most proximal ADHD measurements (4 in addition to the trials included in the study 
by Sonuga-Barke et al.21). The treatment effect was significant (SMD 0.35, 95% CI 0.19-0.50). 
Heterogeneity was significant (χ2 = 32.63, I2 = 45%, p < .05). Restricting the analysis to no-/low-
medication enhanced the effect (n = 11, SMD 0.50, 95% CI 0.24-0.76), but heterogeneity remained 
significant (χ2 = 20.33, I2 = 51%, p < .05). Effects were decreased when outliers (n = 3) were removed but 
remained significant (SMD 0.23, 95% CI 0.12-0.35). Heterogeneity was no longer significant (χ2 = 16.86, 
I2 = 23%, p = .21). None of the trials added since the study by Sonuga-Barke et al.19 had a probably 
blinded measurement, so the prior finding of no treatment effect for ADHD remained unchanged (overall 
SMD 0.02, 95% CI −0.30 to 0.34). 
Fifteen trials had most proximal measurements of conduct problems (10 parent ratings, 3 teacher 
ratings, and 2 clinic observations). Eight trials had probably blinded measurements (1 teacher rating and 7 
observational ratings). Most proximal and probably blinded effects were significant (SMD for most 
proximal 0.26, 95% CI 0.14-0.37; SMD for probably blinded 0.31, 95% CI −0.05 to 0.57). Heterogeneity 
was significant for most proximal (χ2 = 25.87, I2 = 46%, p = .03) but not for probably blinded (χ2 = 14.28, 
I2 = 51%, p = .05) effects. Low-/no-medication studies yielded significant effects for the 2 analyses 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
(n = 7, SMD for most proximal 0.54, 95% CI 0.32-0.76; n = 6, SMD for probably blinded 0.27, 95% CI = 
0.02-0.51). Heterogeneity was not significant for either of these analyses (χ2 for most proximal = 5.96, 
I2 = 37%, p = .43; χ2 for probably blinded = 3.77, I2 = 0%, p = .44). Most proximal effects remained 
significant when outliers (n = 2) were removed (SMD 0.26, 95% CI = 0.12-0.46, χ2 = 14.16, I2 = 22%, 
p = .22). There were no probably blinded outliers. 
Nine trials included most proximal social skills outcomes (4 parent and 5 teacher ratings). Four of 
these included a core specialized social skills training component. The effect was significant (SMD 0.47, 
95% CI 0.15-0.78), as was heterogeneity (χ2 = 22.98, I2 = 65%, p < .01). Restricting the analysis to the 
no-/low-medication studies increased heterogeneity (n = 5, χ2 = 22.08, I2 = 86%, p < .01), so that although 
the effect size increased, it was no longer significant (SMD 0.67, 95% CI −0.20 to 1.55). When outliers 
(n = 1) were removed, the effect remained (SMD 0.30, 95% CI 0.07-0.52) and heterogeneity was 
nonsignificant (χ2 = 4.04, I2 = 0%, p = .54). 
Academic achievement was measured in 9 trials (6 parent or teacher questionnaire-based 
measurements and 3 objective assessments). Seven studies had a specialized component to specially 
target this aspect of impairment. Most proximal effects were significant, and heterogeneity was 
nonsignificant (SMD 0.28, 95% CI 0.06-0.50, χ2 = 14.55, I2 = 45%, p = .07) and persisted when outliers 
(n = 2) were removed (SMD 0.16, 95% CI 0.01-0.31) and heterogeneity was nonsignificant (χ2 = 7.95, 
I2 = 37%, p = .16). There were insufficient no-/low-medication studies to conduct a sensitivity analysis 
(Figure 3). 
There was no association between larger effect sizes and lower Jadad ratings. In fact, for most 
proximal ADHD (t = 2.52, p = .02), higher-quality trials yielded larger effects. Meta-regression did show 
larger effect sizes in trials with younger children for most proximal positive parenting (t = −2.63, p = .03), 
most proximal ADHD (t = −2.09, p = .05), and most proximal conduct problems (t = −2.46, p = .03). 
<H1>Discussion 
The present meta-analyses found blinded evidence that behavioral interventions used to treat children and 
adolescents with ADHD had beneficial effects on important aspects of child and parent functioning. This 
finding contrasts with the lack of blinded evidence relating to ADHD symptoms reported by Sonuga-
Barke et al.19 Specifically, in this analysis, behavioral interventions improved parenting, decreasing 
negative and increasing positive parenting, and decreased children’s comorbid conduct problems. 
Although improving parent functioning was rarely their primary therapeutic goal, nearly all 
behavioral interventions included parent training as a core therapeutic mechanism. Positive effects on 
these outcomes are therefore expectable and, in some ways, a necessary condition for subsequent impacts 
on children’s behavior. Given the need to pool across very diverse and often rather general parenting 
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assessments, a fine-grained analysis of these effects was not possible. For instance, positive parenting 
analyses pooled studies with general assessments of overall increases in positive behaviors/strategies 
(e.g., praise, encouragement61), together with measurements of their appropriate use,25 according to 
therapeutic models. This is important because, according to most models,28 simply increasing levels of 
positive parenting may not be sufficient to produce positive changes in children’s behavior. Objective 
effects on parenting were reflected in improved parenting self-concept: an empowering effect important 
in the process of breaking negative parent–child interaction cycles.31 Increased parenting confidence 
could come from working with experienced therapists who validate parents’ approaches and/or 
implementing behavioral strategies and seeing their positive effects. It also may be an effect of 
psychoeducation that emphasizes the power parents have to influence developmental outcomes.67 Given 
these parenting-specific positive effects, it was perhaps surprising that no beneficial effects were seen on 
parent mental health more generally. It would seem that the high levels of mental health problems that 
often affect parents of children with ADHD are not solely the result of issues around parenting morale, 
but rather reflect a more deep-seated, pervasive psychological aspect, perhaps reflecting shared genetic 
risk for mental health problems within families.68,69 There also was blinded evidence that behavioral 
interventions decreased conduct problems in children with ADHD; benefits of behavioral interventions 
for children seen with conduct disorder extend to those with a full ADHD diagnosis.25 Given the limited 
number of studies with probably blinded measurements and the fact that few had objective measurements 
of child behavior measured at home and school, the authors were unable to assess the generalization of 
child effects across settings. According to most proximal measurements, children’s academic 
performance and social skills also were improved—an effect that is perhaps not surprising, because trials 
included in these analyses often specifically targeted these aspects of impairment with specialized 
packages. If these effects could be corroborated with blinded ratings, this would be encouraging given the 
inconsistent evidence regarding the effects of medication on these outcomes.44,55 
When interpreting the present analysis, it is important to take some factors into account; all meta-
analyses are constrained by the quality and diversity of the studies available for inclusion. First, for nearly 
all analyses, there was significant SMD heterogeneity among studies that may reflect the variety of 
intervention and outcome types analyzed. In most, although not all, cases, removing outliers identified 
using funnel plots decreased this heterogeneity while leaving treatment effects significant. Second, the 
authors could not establish how many parents had definite parenting or mental health problems, or how 
many children had clinical levels of conduct problems. Because participants were specifically selected for 
ADHD in childhood, it is likely that substantial numbers of individuals were unaffected by these 
additional problems. As a consequence, effect sizes seen for these outcomes, given the smaller room for 
improvement, are likely to be an underestimate of the true effects of behavioral interventions. Third, 
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Sonuga-Barke et al.19 raised questions about the status of the probably blinded measurements as valid 
outcomes. This is because they were often based on relatively small snapshots of behavior or a rating by a 
teacher who may not know the child well. However, in the present study, these measurements proved to 
be sensitive to treatment-related change. Fourth, this evaluation did not explore the impact on long-term 
outcomes, where one might predict a more robust impact of behavioral interventions. Fifth, although the 
authors established that parenting improved on rather artificial trial-based assessments, these may not 
have been able to capture improvements in everyday life situations. Sixth, there were insufficient studies 
to explore whether interventions specifically tailored for ADHD64 were more effective than parenting 
interventions designed to treat more general childhood behavior problems or other aspects of impairment 
(social and academic skills). Seventh, the pool of trials meeting inclusion criteria was dominated by 
parenting interventions. This meant that the present analysis says little specifically about the value of 
child- or teacher-focused interventions. Eighth, in a related manner, no trials included measurements of 
changes in adult responses to children with ADHD other than parents. Ninth, the authors decided not to 
conduct or report an analysis of publication bias using techniques such as funnel plots because their 
interpretation is equivocal when based on a small number of studies, with difficulty in particular 
distinguishing between the effects of study heterogeneity and publication bias with sparse data.36 
In summary, although more evidence is required before behavioral interventions can be supported as 
a front-line treatment for core ADHD symptoms, the authors found evidence that they do have beneficial 
effects on parenting and parents’ sense of empowerment and independently corroborated effects on 
conduct problems in children with ADHD. Initial evidence from proximal outcomes relating to academic 
achievement and social skills needs to be confirmed by probably blinded analyses and greater exploration 
is needed on the moderating impact of child age on intervention outcome. 
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Figure 1 Flowchart showing the selection of trials. See Supplement 1 (available online) for specific 
reasons for exclusion. 
Figure 2 Parental outcomes. Note: CI = confidence interval; MPROX = most proximal rating; MTA = 
National Institute of Mental Health Multimodal Treatment Study of Attention-Deficit/Hyperactivity 
Disorder; PBLIND = probably blinded rating; SMD = standardized mean difference. 
Figure 3 Child outcomes. Note: ADHD = attention-deficit/hyperactivity disorder; CI = confidence 
interval; MPROX = most proximal rating; MTA = National Institute of Mental Health Multimodal 
Treatment Study of Attention-Deficit/Hyperactivity Disorder; PBLIND = probably blinded rating; SMD = 
standardized mean difference. 
Table 1 Characteristics of Included Studies 
Trial Treatment Control Jadad 
Rating 
Sample 
Size 
Age 
Rang
e (y) 
Boys
, % 
Medicated 
for ADHD, 
% 
 Delivery Type   T C    
Abikoff et al. 
(2012)34 
parent 
and 
teacher 
behavioral 
training 
wait list 2 61 33 8-11 69 36 
Antshel and Remer 
(2003)43 
child 
and 
parent 
social skills 
training 
wait list 2 80 40 8-12 75 93 
Bloomquist et al. 
(1991)44 
child, 
parent, 
and 
teacher 
CBT wait list 2 20 16 8.58 
mean 
69 0 in 
analysis 
Bor et al. (2002)24 parent behavioral 
training 
wait list 3 26 37 3.6 
mean 
73 0 
Brown et al. (1986)45 child self-control 
training 
attention 
control 
2 10 8 5-13 85 0 
Chacko et al. (2009)46 parent behavioral 
training 
wait list 2 40 40 5-12 73 38.75 
Evans et al. (2011)47 parent 
and 
child 
behavioral and 
social skills 
training 
TAU 1 31 18 11-13 71 57 
Fabiano et al. 
(2010)48 
children daily report card TAU 2 33 30 6-12 86 52 
Fabiano et al. 
(2012)49 
parent behavioral 
training 
wait list 2 27 28 6-12 87 54 
Fehlings et al. 
(1991)50 
parent 
and 
child 
CBT attention 
control 
2 13 13 8-11 100 0 
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Hoath and Sanders 
(2002)51 
parent behavioral 
training 
wait list 1 9 11 5-9 76 70 
Horn et al. (1991)52 parent 
and 
child 
behavioral and 
self-control 
training 
placebo 2 16 16 7-11 no 
info 
0 
Jones et al. (2008)53 parent behavioral 
training 
wait list 3 50 29 3.8 
mean 
68 0 
Kapalka (2005)54 parent behavioral 
training 
wait list 0 45 41 5-10 100 no info 
Langberg et al. 
(2008)55 
child 
and 
parent 
organizational 
skills training 
wait list 1 24 13 grade
s 4-7 
83 43 
Langberg et al. 
(2012)35 
child 
and 
parent 
organizational 
skills training 
wait list 2 23 24 grade
s 6-8 
74 66 
Mikami et al. 
(2011)56 
parent parent coaching 
on social skills 
wait list 2 32 30 6-10 68 64.5 
Molina et al. (2008)57 child 
and 
parent 
organizational 
skills training 
communit
y 
2 11 9 grade
s 6-8 
75 31 
MTA (1999, 2000, 
2006)40-42 
child, 
parent, 
and 
teacher 
Multicomponent
: home, school, 
and camp 
TAU 4 144 146 8.33 
mean 
80 47 
Pfiffner and 
McBurnett (1997)33 
child 
and 
parent 
behavioral 
training and 
CBT 
wait list 2 9 9 8-10 72 44 
Pfiffner et al. 
(2007)58 
child 
and 
parent 
behavioral 
training and 
CBT 
wait list 2 36 33 7-11 66 3 
Pisterman et al. 
(1989)59 
parent behavioral 
training 
wait list 3 23 23 4.1 
mean 
80 11 
Pisterman et al. 
(1992)60 
parent behavioral 
training 
wait list 3 23 22 4.1 
mean 
91 9 
Power et al. (2012)61 child 
and 
parent 
behavioral and 
academic skills 
training 
attention 2 100 99 grade
s 2-6 
68 43 
Sonuga-Barke et al. 
(2001)62 
parent behavioral 
training 
counselin
g 
3 30 28 2-4 62 0 
Sonuga-Barke et al. 
(2004)63 
parent behavioral 
training 
wait list 2 59 30 2-4 no 
info 
0 
Thompson et al. 
(2009)64 
parent behavioral 
training 
wait list 4 21 20 2-6 73 0 
Tracey and Tripp 
(2005)65 
parent stress 
management 
wait list 2 20 20 6-15 88 88 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Van den Hoofdakker 
et al. (2007)66 
parent behavioral 
training 
TAU 2 48 48 4-12 76 40 
Webster-Stratton et 
al. (2011)25 
parent 
and 
child 
behavioral 
training 
wait list 3 49 50 6.4 
mean 
75 13 
Note: ADHD = attention-deficit/hyperactivity disorder; C = control; CBT = cognitive behavioral therapy; grade 
= school year; MTA = National Institute of Mental Health Multimodal Treatment Study of Attention-
Deficit/Hyperactivity Disorder; no info = no information provided in article; T = treatment; TAU = treatment as 
usual. 
 
Table 2  Measurements Used in Each Trial for the Different Outcomes 
  Child Parent 
  ADHD CP SS AS MH SC PP NP 
Abikoff et 
al.34 
MPROX    APRSa    COSSa 
 PBLIND         
Antshel 
and 
Remer43 
MPROX   SSRSa      
 PBLIND         
Bloomquis
t et al.44 
MPROX CTRSb  SSCSA
a
 
     
 PBLIND         
Bor et al.24 MPROX ECBIa ECBIa   DASSa PSOCa  PSa 
 PBLIND  FOSRc      FOSRc 
Brown et 
al.45 
MPROX CPRSa ACTeRS
b
 
ACTeR
Sb 
WRAT
d
 
    
 PBLIND ACRSb        
Chacko et 
al.46 
MPROX DBDa DBDa IRSa  BDIa  DPICSc DPICSc 
 PBLIND       DPICSc DPICSc 
Evans et 
al.47 
MPROX ADHDR
Sa 
 IRSb IRSb     
 PBLIND         
Fabiano et 
al.48 
MPROX DBDb DBDb  APRSa     
 PBLIND         
Fabiano et 
al.49 
MPROX  ECBIa     DPICSc DPICSc 
 PBLIND       DPICSc DPICSc 
Fehlings et 
al.50 
MPROX WWASa        
 PBLIND         
Hoath and 
Sanders51 
MPROX CAPSa ECBIa   DASSa PSBCa  PSa 
 PBLIND CAPSb SESBIb       
Horn et 
al.52 
MPROX CPRSa        
 PBLIND         
Jones et 
al.53 
MPROX CPRSa        
 PBLIND         
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Kapalka54 MPROX  SSQb       
 PBLIND         
Langberg 
et al.55 
MPROX    APRSa     
 PBLIND         
Langberg 
et al.35 
MPROX VADPR
Sa 
  HPCa    COSSa 
 PBLIND         
Mikami et 
al.56 
MPROX   SSRSa    PBIPCc PBIPCc 
 PBLIND       PBIPCc PBIPCc 
Molina et 
al.57 
MPROX  ACPSa  SGR     
 PBLIND         
MTA40-42 MPROX SNAPa SNAPa  WIATd BDIa  PCRQa PCRQa 
 PBLIND classobc classobc     OBS  
Pfiffner 
and 
McBurnett
33
 
MPROX   SSRSa      
 PBLIND         
Pfiffner et 
al.58 
MPROX   SSRSa      
 PBLIND         
Pisterman 
et al.59 
MPROX  clinobc     clinobc clinobc 
 PBLIND  clinobc     clinobc clinobc 
Pisterman 
et al.60 
MPROX clinobc clinobc     clinobc clinobc 
 PBLIND clinobc clinobc     clinobc clinobc 
Power et 
al.61 
MPROX SNAPa SNAPa  APRSb  PESa PCRQa PCRQa 
 PBLIND         
Sonuga-
Barke et 
al.62 
MPROX PACSa PACSa   GHQa PSOCa   
 PBLIND homeobc        
Sonuga-
Barke et 
al.63 
MPROX PACS    GHQa PSOCa   
 PBLIND         
Thompson 
et al.64 
MPROX PACS PACS   GHQa  GIPCIc EEe 
 PBLIND homeobc GIPCIc     GIPCIc EEe 
Tracey 
and 
Tripp65 
MPROX     BDIa PLOCa  PSa 
 PBLIND         
Van den 
Hoofdakk
ar et al.66 
MPROX CPRSa    PSIa PSIa   
 PBLIND         
Webster-
Stratton et 
al.25 
MPROX CPRSa CPRSa SCSa    PPIa PPIa 
 PBLIND COCA-R      DPICSc DPICSc 
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, 
DPICS1
7
-OBS 
Note: Superscript letter codes who provided the assessment; superscript number gives full name of test. ACPS = 
Aggression and Conduct Problem Scale; ACRS = Abbreviated Conners Rating Scale; ACTeRS = ACTeRS 
ADD-H Comprehensive Teachers Rating Scale; ADHD = attention-deficit/hyperactivity disorder; ADHDRS = 
Attention Deficit Hyperactivity Disorder Rating Scale; APRS = Academic Performance Rating Scale; AS = 
academic skills; BDI = Beck Depression Inventory; CAPS = Child Attention Problem Rating Scale; classob = 
classroom observation; clinob = clinic observation; COCA-R = Coder Observation of Classroom Adaption–
Revised: Cognitive Concentration; COSS = Children’s Organizational Skills Scale; CP = conduct problems; 
CPRS = Conners Parent Rating Scale–Hyperactivity; CTRS = Conners Teachers Rating Scale; DASS = 
Depression Anxiety and Stress Scale; DBD = Disruptive Disorders Rating Scale; DPICS = Dyadic Parent–Child 
Interaction Coding System; ECBI = Eyberg Child Behavior Inventory; EE = Expressed Emotion measured using 
the Pre-school Five Minute Speech Sample; FOSR = Family Observation Schedule; GHQ = General Health 
Questionnaire; GIPCI = Global Impressions of Parent Child Interaction Revised; homeob = home observation of 
on-task behavior; HPC = Homework Problem Checklist; IRS = Impairment Rating Scale; MH = mental health; 
MPROX = most proximal rating; MTA = National Institute of Mental Health Multimodal Treatment Study of 
Attention-Deficit/Hyperactivity Disorder; NP = negative parenting; OBS = observed constructive parenting; 
PACS = Parent Account of Childhood Symptoms Interview; PBIPC = Parental Behavior in Parent–Child 
Interaction; PBLIND = probably blinded rating; PCRQ = Parent Child Relationship Questionnaire; PES = 
Parent as Educator; PLOC = parents locus of control; PP = positive parenting; PPI = ??; PS = Parenting Scale; 
PSBC = Problem Setting and Behavior Checklist; PSI = Parenting Stress Inventory; PSOC = Parenting Sense of 
Competence Scale; SC = self-concept; SCS = Social Competence Scale; SESBI = Sutter-Eyberg Student 
Behavior Inventory Revised; SGR = school grade records; SNAP = Pelham Swanson and Nolan Questionnaire; 
SS = social skills; SSCSA = Walker-McConnel Scale of Social Competence and School Adjustment; SSQ = 
Social Situations Questionnaire; SSRS = Social Skills Rating Scale; VADPRS = Vanderbilt ADHD Diagnostic 
Parent Rating Scale; WIAT = Wechsler Individual Achievement Test; WRAT = Wide Range Achievement Test; 
WWAS = Werry Weiss Activity Scale. 
aParent. 
bTeacher. 
cObservation. 
dAcademic skills test. 
eSpeech sample. 
 
Supplement 1 Information on Excluded Studies 
Study Reasons for Exclusion 
Abikoff and Gittelman 
(1985)1 
not a behavioral intervention; study explores cognitive training 
Abikoff et al. (2004)2 no appropriate control group; behavioral intervention adjunctive to medication 
Abikoff et al. (2004)3 no appropriate control group; behavioral intervention adjunctive to medication 
Altemeier and Horwitz 
(1997)4 
not randomized 
Anastopolos et al. (1993)5 not randomized 
Arnold et al. (2003)6 MTA study that did not add additional outcomes to the included studies 
Barkley et al. (1992)7 no appropriate control group; this study is a comparison of 3 active therapies 
Barkley et al. (1996)8 reports violation of randomization 
Barkley et al. (2000)9 reports violation of randomization in 8 children 
Barkley et al. (2001)10 no appropriate control group; this study compares 3 different combinations of 
intervention but does not have a control condition 
Carlson et al. (1992)11 not randomized 
Chacko et al. (2003)12 not a behavioral intervention; this is a medication study 
Christensen and Sprague 
(1973)13 
not randomized 
Christensen (1975)14 no appropriate control group; this is a within-subject design 
Cohen et al. (1981)15 not randomized 
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Cunningham et al. (1995)16 not a specific ADHD sample 
Döpfner et al. (2004)17 no appropriate control group; this study applies an adaptive and individually tailored 
approach to treatment 
Dubey and O’Leary 
(1983)18 
randomization unclear; groups were assigned so that age and gender were evenly 
distributed 
Epstein et al. (2007)19 not a behavioral intervention 
Evans et al. (2005)20 not randomized 
Fabiano et al. (2009)21 no appropriate control group; this study is a comparison of 2 behavioral interventions 
Firestone et al. (1981)22 no control group 
Firestone et al. (1986)23 no control group and follow-up of a previously excluded study 
Frankel et al. (1997)24 children with and without ADHD included in sample 
Gerber-von Müller et al. 
(2009)25 
no appropriate treatment control group 
Gonzalez and Sellers 
(2002)26 
ADHD status of children unclear 
Hanisch et al. (2010)27 not a specific ADHD sample 
Hantson et al. (2012)28 not randomized 
Hechtman et al. (2004)29 no appropriate control group; behavioral intervention adjunctive to medication 
Hechtman et al. (2004)30 no appropriate control group; behavioral intervention adjunctive to medication 
Hinshaw et al. (1984)31 no appropriate control group; behavioral intervention adjunctive to medication 
Hinshaw et al. (1984)32 no appropriate control group; behavioral intervention adjunctive to medication 
Hinshaw et al. (2000)33 MTA study that did not add any additional outcomes 
Horn et al. (1987)34 no appropriate control group; this study is a comparison of 2 behavioral interventions 
Horn et al. (1990)35 no appropriate control group; this study is a comparison of 2 behavioral interventions 
Hupp et al. (2002)36 case study 
Iolango et al. (1993)37 same dataset as Horn et al.,35 which was excluded 
Jensen et al. (2001)38 MTA study that did not add additional outcomes 
Jensen et al. (2004)39 MTA study that did not add additional outcomes 
Jensen et al. (2007)40 MTA study that did not add additional outcomes 
Kapalka (2004)41 not a behavioral intervention 
Kapalka (2005)42 weak randomization procedure 
Kern et al. (2007)43 no appropriate control group; this study is a comparison of 2 behavioral interventions 
Kienle et al. (2009)44 not randomized 
Klein and Abikoff (1997)45 no appropriate control group; this study explores combinations of medication and 
behavioral intervention 
Klein et al. (2004)46 methodology article on design of study by Hechtman29,30; no control group 
Lerner et al. (2011)47 randomization unclear 
Lloyd et al. (2010)48 not a behavioral intervention 
McGrath et al. (2011)49 study met criteria for inclusion, but data were not amenable to analysis, and the 
investigators were unable to provide the data 
McNeil et al. (1991)50 randomization unclear 
Meyer and Kelley (2007)51 no appropriate control; this study compares parent with self-monitoring for 
homework problems 
Mikami et al. (2013)52 no appropriate control; this study compares 2 behavioral interventions 
Miranda et al. (2002)53 randomization unclear 
Odom (1996)54 randomization unclear 
Osterberg and Rydell 
(2012)55 
randomization unclear; not an entirely ADHD sample 
O’Leary et al. (1976)56 insufficient detail in summary statistics to allow calculation of SMD 
Papazian et al. (2009)57 not a behavioral intervention 
Pariseau et al. (2010)58 no appropriate control group; this is a within-subject design 
Pelham (1977)59 case study 
Pelham et al. (1993)60 no appropriate control group; this is a within-subject design 
Pelham (1999)61 review article; no data 
Pelham and Gnagy (1999)62 review article; no data 
Pelham et al. (2000)63 no control group; same sample as MTA comparing behavioral and combined groups 
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Pfeiffer et al. (2008)64 not a specific ADHD sample and not a behavioral intervention 
Pfeiffer et al. (2007)65 not fully randomized 
Poulsen et al. (2010)66 not fully randomized 
Presentación Herrero et al. 
(2010)67 
not randomized 
Rapport et al. (1982)68 case study (2) 
Rieppi et al. (2002)69 MTA study that did not add additional outcomes 
Rosén et al. (1984)70 not randomized 
Rutter and Sroufe (2000)71 review article; no data 
Sanders et al. (2007)72 not a specific ADHD sample 
Sayal et al. (2010)73 not a behavioral intervention 
Shafto and Sulzbacher 
(1977)74 
case study 
Schumann et al. (1998)75 not a specific ADHD sample 
Scott et al. (2010)76 not a specific ADHD sample 
Shaffer et al. (2001)77 not a behavioral intervention 
So et al. (2008)78 no appropriate control group; behavioral intervention adjunctive to medication 
Springer and Reddy 
(2010)79 
not randomized 
Strayhorn and Weidman 
(1989)80 
not a specific ADHD sample 
Strayhorn and Bickel 
(2002)81 
no appropriate control group; comparison of 2 behavioral approaches 
Storebø et al. (2012)82 behavioral intervention adjunctive to medication 
Swanson et al. (2001)83 reanalysis of MTA study; no new outcomes added 
Thorell (2009)84 not adequately randomized; allocation to condition influenced by other factors 
Thurston (1979)85 randomization unclear 
Tutty et al. (2003)86 no appropriate control group; behavioral intervention adjunctive to medication 
Van der Oord et al. (2007)87 no appropriate control group; behavioral intervention adjunctive to medication 
Waxmonsky et al. (2008)88 no appropriate control group; behavioral intervention adjunctive to medication 
Waxmonsky et al. (2010)89 no appropriate control group; behavioral intervention adjunctive to medication 
Wolraich et al. (1978)90 no appropriate control group 
Wulbert and Dries (1977)91 case study 
Note: ADHD = attention-deficit/hyperactivity disorder; MTA = National Institute of Mental Health Multimodal 
Treatment Study of Attention-Deficit/Hyperactivity Disorder; SMD = standardized mean difference. 
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